Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;60(6):917-920.
doi: 10.1038/s41409-025-02584-4. Epub 2025 Apr 13.

Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE

Charlotte Calvo #  1   2 , Cléo Hautefeuille #  3 , Loïc Vasseur  4   5 , Florian Chevillon  5 , Charlotte Nazon  6 , Benedicte Bruno  7 , Marc Ansari  8   9 , Arthur Sterin  10 , Anne Sirvent  11 , Audrey Grain  12 , Marie Angoso  13 , Virginie Gandemer  14 , Pascale Schneider  15 , Carine Halfon-Domenech  16 , Pierre-Simon Rohrlich  17 , Cécile Pochon  18 , Catherine Paillard  6 , Stephanie Nguyen Quoc  19 , Nicole Raus  20 , Marion Strullu  3 , Françoise Méchinaud  3 , Nathalie Dhedin  5 , Jean-Hugues Dalle  3   21
Affiliations
Free article

Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE

Charlotte Calvo et al. Bone Marrow Transplant. 2025 Jun.
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and patient consent: Patients or legal guardians provided written informed consent for data collection and use for analysis, in accordance with the Declaration of Helsinki. This study was approved by SFGM-TC and SFCE HSCT committees and registered on Health Data Hub (F20230327154245).

References

    1. Ruggeri A, Galimard JE, Paina O, Fagioli F, Tbakhi A, Yesilipek A, et al. Outcomes of unmanipulated haploidentical transplantation using post-transplant cyclophosphamide (PT-Cy) in pediatric patients with acute lymphoblastic leukemia. Transpl Cell Ther. 2021;27:424.e1–424.e9. - DOI
    1. Fierro-Pineda JC, Tsai HL, Blackford A, Cluster A, Caywood E, Dalal J, et al. Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias. Blood Adv. 2023;7:5639–48. - DOI - PubMed - PMC
    1. Ruggeri A, Santoro N, Galimard JE, Kalwak K, Algeri M, Zubarovskaya L, et al. Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study. Haematologica. 2024;109:2122–30. - PubMed - PMC
    1. Kawahara Y, Morimoto A, Inagaki J, Koh K, Noguchi M, Goto H, et al. Unrelated cord blood transplantation with myeloablative conditioning for pediatric acute lymphoblastic leukemia in remission: prognostic factors. Bone Marrow Transplant. 2021;56:357–67. - DOI - PubMed
    1. Peters C, Dalle JH, Locatelli F, Poetschger U, Sedlacek P, Buechner J, et al. Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study. J Clin Oncol. 2021;39:295–307. - DOI - PubMed